Michal Geva
Senior Vice President, Head of Research at Prilenia- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Prilenia
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Senior Vice President, Head of Research
-
Jun 2023 - Present
-
-
VP, Head of Research
-
Oct 2021 - Jun 2023
-
-
Head of Research
-
Jun 2020 - Oct 2021
-
-
Head of Non-clinical Development and Academic Affairs
-
Apr 2018 - Jun 2020
-
-
-
Teva Pharmaceuticals
-
Israel
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Associate Director, CNS Pharmacology Project Leader
-
Jan 2015 - Mar 2018
• Responsible for nonclinical development and pharmacology leadership of CNS drugs, specialty and repurposing projects • Proactively lead and supervised preclinical evaluations for Teva drugs in several neurodegeneration therapeutic areas: Huntington Disease, Alzheimer’s, Parkinson’s disease, Rett Syndrome, ALS, Familial Dysautonomia, and Retinal degeneration.• Developed and executed strategic development plans for early CNS drugs• Pharmacology leadership including interactions with multidisciplinary teams, and managing timeline and budget plans for nonclinical studies during all stages in pipeline development • Provided regulatory support including NDA contributions and functional representation for FDA/EMA interactions, building IB/IND documents, tracking IND-enabling studies and coordinating transfer of knowledge to commercial, legal, clinical, regulatory functions and senior management• Participated in global cross-functional teams that set strategic direction and articulated value proposition for potential products • Built a network of academic collaborations supporting my projects, working closely and globally with KOLs in the neurodegenerative field, as well as establishing relationships with CROs and vendors • Led and organized several advisory board meetings involving disease state thought leaders and Teva R&D senior management• Member of Teva's Opportunity and Strategy Review Team - Due Diligence of companies and CNS related compounds Show less
-
-
Senior Manager , Project Leader
-
Jul 2012 - Jan 2015
-
-
-
UCSF Health
-
United States
-
Hospitals and Health Care
-
700 & Above Employee
-
Post doctoral scholar at UCSF. Research Adviser: Nobel Laureate Stanley.B. Prusiner
-
Jun 2008 - Dec 2011
-
-
-
XTL Biopharmaceuticals Ltd.
-
Israel
-
Pharmaceutical Manufacturing
-
Scientist
-
2002 - 2004
-
-
Education
-
Tel Aviv University
PhD, Cell research & immunology